{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:14:23Z","timestamp":1793524463858,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.vaccine.2025.127720","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T04:35:17Z","timestamp":1757824517000},"page":"127720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Acceptance of chikungunya vaccination: a rapid survey in Reunion island during an epidemic"],"prefix":"10.1016","volume":"64","author":[{"given":"Rodolphe","family":"Manaquin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa","family":"Desmoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liem Binh","family":"Luong Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Kornblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Deparis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Ferdynus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Bertolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Verger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"D'Ortenzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Pasquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Eldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"G\u00e9rardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Mosnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127720_bb0005","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1473-3099(23)00810-1","article-title":"Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study","volume":"24","author":"Kang","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127720_bb0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1473-3099(23)00739-9","article-title":"Risk of death following chikungunya virus disease in the 100 million Brazilian Cohort, 2015-18: a matched cohort study and self-controlled case series","volume":"24","author":"Cerqueira-Silva","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127720_bb0015","series-title":"Global chikungunya epidemiology update","author":"WHO","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127720_bb0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(07)70107-X","article-title":"Chikungunya, an epidemic arbovirosis","volume":"7","author":"Pialoux","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127720_bb0025","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1017\/S0950268808001167","article-title":"Atypical chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on R\u00e9union","volume":"137","author":"Economopoulou","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2025.127720_bb0030","unstructured":"Sant\u00e9 publique France. Chikungunya et dengue \u00e0 La R\u00e9union: Bulletin du 25 f\u00e9vrier 2025 [Internet]. Saint-Maurice: Sant\u00e9 publique France; 2025 [cited 2025 Sep 10]. Available from: https:\/\/www.santepubliquefrance.fr\/regions\/ocean-indien\/documents\/bulletin-regional\/2025\/chikungunya-et-dengue-a-la-reunion.-bulletin-du-25-fevrier-2025."},{"key":"10.1016\/j.vaccine.2025.127720_bb0035","unstructured":"Sant\u00e9 publique France. Surveillance sanitaire \u00e0 La R\u00e9union: Bulletin du 27 ao\u00fbt 2025 [Internet]. Saint-Maurice: Sant\u00e9 publique France; 2025 [cited 2025 Sep 10]. Available from: https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/maladies-a-transmission-vectorielle\/chikungunya\/documents\/bulletin-national\/chikungunya-dengue-zika-et-west-nile-en-france-hexagonale.-bulletin-de-la-surveillance-renforcee-du-27-aout-2025."},{"key":"10.1016\/j.vaccine.2025.127720_bb0040","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160173","article-title":"Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera","volume":"7","author":"Roques","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2025.127720_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003764","article-title":"High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines","volume":"9","author":"Yoon","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.127720_bb0050","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","article-title":"Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"401","author":"Schneider","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127720_bb0055","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S1473-3099(24)00357-8","article-title":"Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study","volume":"24","author":"McMahon","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127720_bb0060","series-title":"Les autorit\u00e9s sanitaires retirent les personnes de 65 ans et plus des cibles de la campagne de vaccination contre le chikungunya avec le vaccin IXCHIQ \u00e0 La R\u00e9union et \u00e0 Mayotte","author":"DGOS","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127720_bb0065","series-title":"EMA starts review of Ixchiq (live attenuated chikungunya vaccine)","author":"European Medicines Agency","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127720_bb0070","series-title":"FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live)","author":"FDA","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127720_bb0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1473-3099(24)00458-4","article-title":"Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents","volume":"25","author":"Buerger","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127720_bb0080","unstructured":"Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/39146946\/ (accessed January 31, 2025)."},{"key":"10.1016\/j.vaccine.2025.127720_bb0085","unstructured":"Phase: Trial of the VLP-Based Chikungunya Vaccine PXVX0317 - Google Scholar n.d. https:\/\/scholar.google.com\/scholar_lookup?title=A%20phase%203%20trial%20of%20the%20VLP-based%20chikungunya%20vaccine%20PXVX0317&publication_year=2023&author=Bavarian%20Nordic (accessed January 28, 2025)."},{"key":"10.1016\/j.vaccine.2025.127720_bb0090","article-title":"Chikungunya: a decade of burden in the Americas","volume":"30","author":"de Souza","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.vaccine.2025.127720_bb0095","unstructured":"A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/32445713\/ (accessed February 3, 2025)."},{"key":"10.1016\/j.vaccine.2025.127720_bb0100","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/14760584.2020.1825945","article-title":"Restoring confidence in vaccines in the COVID-19 era","volume":"19","author":"Verger","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127720_bb0105","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1016\/j.vaccine.2011.06.107","article-title":"Factors associated with uptake of vaccination against pandemic influenza: a systematic review","volume":"29","author":"Bish","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127720_bb0110","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/14760584.2017.1381020","article-title":"Socioeconomic differences in childhood vaccination in developed countries: a systematic review of quantitative studies","volume":"16","author":"Bocquier","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127720_bb0115","series-title":"Chikungunya\u00a0: en raison de l\u2019acc\u00e9l\u00e9ration de la diffusion de l\u2019\u00e9pid\u00e9mie, le pr\u00e9fet d\u00e9clenche le niveau 3 du plan ORSEC \u00e0 La R\u00e9union","author":"Pr\u00e9fet de la R\u00e9union","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127720_bb0120","unstructured":"Sant\u00e9 Publique France. Vaccination \u00e0 La R\u00e9union. Bilan de la couverture vaccinale en 2023. 2024."},{"key":"10.1016\/j.vaccine.2025.127720_bb0125","unstructured":"INSEE. L'essentiel sur\u2026 La R\u00e9union n.d."},{"key":"10.1016\/j.vaccine.2025.127720_bb0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2334-8-99","article-title":"Estimating chikungunya prevalence in La R\u00e9union Island outbreak by serosurveys: two methods for two critical times of the epidemic","volume":"8","author":"G\u00e9rardin","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127720_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126483","article-title":"Chikungunya vaccine development, challenges, and pathway toward public health impact","volume":"42","author":"Maure","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127720_bb0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/08901171231200778","article-title":"A scoping review on gender\/sex differences in COVID-19 vaccine intentions and uptake in the United States","volume":"38","author":"Sileo","year":"2024","journal-title":"Am J Health Promot"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:52:38Z","timestamp":1769025158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25010175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"alternative-id":["S0264410X25010175"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127720","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acceptance of chikungunya vaccination: a rapid survey in Reunion island during an epidemic","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127720"}}